In this note we examine the effect of competing activator-inhibitor control mechanisms on tissue growth. The motivation for this problem arises from complementary levels of description for models of cancer growth [ 1 ] - [ 3] . This simple generalization of a one-dimensional model [ 4] is easily accessible to undergraduate students of applied mathematics, and has the advantage that it is suggestive of behavior known to occur in some realistic biological systems. This does not, of course, imply any more than the possibility that models suitably generalized to more realistic geometries and biology may be of value in describing observed tissue growth characteristics. We use the notation of Glass [ 4] .
Consider a one-dimensional slab of "target tissue" embedded in "host tissue" of infinite extent. The host tissue is considered to be passive insofar as it is permeable to enzymes produced within the target tissue, and as the latter grows, the former offers no packing resistance to slow down or stop the growth of target tissue. We assume that two basic enzymes are produced at a uniform rate within the target tissue: the "inhibitor" has concentration C1 and production rate P 1 and the "activator" has concentration C2 and production rate P2 • If A; and D; represent the respective depletion ( or decay) rates and diffusion coefficients of enzyme i ( i = 1 or 2) then under the assumption of diffusive equilibrium the C; satisfy equations of the form 
Glass solved system ( I ) and ( 2) for a single growth inhibitor with concentration C [ 4] , i.e., no activator/ inhibitor interaction. Later, however, Shymko and Glass [ 5] did solve system (1) for point sources, i.e., S(x) oc f[C;]o(x -x;), i,j = l, 2. We are interested here in uniform production rates across the target tissue, and subsequent limiting tissue sizes.
The formal solution to ( 1 ) and ( 2) is
where the Green's function 
The conditions implicit on
(These conditions do not all have to be imposed: (i) and (ii) are implied by (iii) and (iv).)
The solutions are as follows:
We note that
Define the following dimensionless quantities:
Furthermore, define the following functions:
f;(n;)=-ln --1 ( n; )
IX;
n; -1 (n; > 1 ),
2n; -1 ( n;>~)-(Notethatg;(n;) = 2f;(2n;).) We consider various different states throughout the tissue.
.e., no mitosis throughout the tissue (switch I). Since C; ( x) is a monotone decreasing function, we require the following conditions to hold simultaneously: C1 ( I L/2 I)> 00 and C2(0) < ¢ 0 • After a little algebra it follows that L must satisfy the condition
. We now require that C1(I L/21) > 0o and C2(I L/21) > <Po, L>max {f;(n;)}.
It is necessary that C1 (0) < 00 and C2(0) < ¢ 0 , implying (12) L < min { g; ( n; ) } .
. This requires C1(0) < 00 and C2( I L/2 I)> <Po, i.e.,
We are now in the position to prove several lemmas. Let p = 1X2/21X1 and n; > 1. Then we have Lemma 1.
Proof. Since n / ( n -1) > ( 2n / ( 2n -1 ) ) 2 , it follows from the nature of ln x, x > 0, that ln (n/(n -1 )) > 2 ln (2n/(2n -1 ) ), i.e.,.fi (n) > 2pg2(n), establishing the result. LEMMA 2. For any given p, 0 ~ p ~ ½, there exists a unique n = nc, 1 < nc < oo, such that Ji ( nc) = g2 ( nc). Equivalently, for any given n > 1, there exists a p = Pc < ½ such that Ji (n) = g2(n ).
Proof. We define h(n) = ln (2n/(2n -1 ))/ln (n/(n -1 )), n > 1. It is seen that limn .... 1 + h ( n) = 0 + and, using l'Hopital's rule, limn .... 00 h ( n) = ½ . Either h -½ monotonically or h'(n) = 0 for at least one n > 1. After some algebra it can be shown that this latter result occurs if and only if
Clearly this cannot occur for n > 1, since ( 14) implies n < 1. Thus h is monotone increasing (see Fig. 1 ). Therefore, for p < ½ there is a unique n = nc such that h(nc) = p, i.e., (15) Hence we have the following corollary. COROLLARY 1. For each p < ½ there exists a unique n = nc > 1 such that h(nc) > pfor n > nc, and h(nc) < pfor 1 < n < nc. That is, g2 (n) > fi(n)for n > nc, and gz(n) <Ji (n)for 1 < n < nc.
From equations ( 10) and ( 13) this signifies that if n is induced to change through the value nc, the tissue growth may change from zero mitotic rate to M>, or vice versa. That is, the graphs offt(n,) and g2(n2 ), plotted against the same independent variable n, = n2 = n, actually intersect and cross for p < ½, i.e., for a 2 < a 1 , at n = nc (see Fig. 2 ). Figure 2 depicts the graph of g2(n2 } superimposed on the graph of ft (ni). This provides a convenient description of the regions of the ft -n1 andg2 -n2 graphs wherein growth characteristics corresponding to (10) and (13) may occur. Sincefi(n)/h(n) = a 2 / a 1 = 2p, we are in a position to describe condition (11) graphically, in a similar
. Condition (12) can be similarly described.
Clearly the most interesting implication for a biological context is that this model ( highly simplified though it is) indicates that a change may occur from no mitotic activity in [ -L/2, L/2] to accelerated mitosis in [ -L/2, L/2] ( or vice versa) as n1 and n2 change appropriately through nc for p <½.(These changes inn; may occur as a result of internal or external factors affecting the state of the tissue-it is beyond the scope of this note to 
FIG. 2.
Composite representation of fi(n) and g2(n)for p = a2/2a1 < ½. speculate further.) For given p < ½, this critical value of n, nc, may be found from equation ( 15 ) . Note that this behavior change is not the same as that discussed by Glass [ 4] , in which there is only inhibitor present and the transition from "stable" to "unstable" tissue growth occurs at n = 1 ( where the expression for Ji is undefined).
